Skip to main content
padlock icon - secure page this page is secure

Self-aggregated Nanoparticles of Cholesterol-modified Pullulan Conjugate as a Novel Carrier of Mitoxantronep

Buy Article:

$68.00 + tax (Refund Policy)

Cholesterol-modified pullulan (CHSP) conjugate with succinyl linkages was synthesized and characterized by fourier transform infrared (FT-IR), proton nuclear magnetic resonance (1H NMR) and X-ray diffraction (XRD). The degree of substitution (DS) of cholesterol moiety determined by 1H NMR ranged from 3.87 to 5.70 cholesterol groups per hundred glucose units. CHSP self-aggregated nanoparticles were prepared by probe sonication in aqueous media and analyzed by dynamic laser light-scattering (DLS), zeta potential, transmission electron microscopy (TEM) and the fluorescence probe technologies. These novel nanoparticles were almost spherical in shape, and their size, ranging from 73.0 to 51.8 nm, could be controlled by DS. The zeta potentials of CHSP self-aggregated nanoparticles were near zero in aqueous media. The value of critical aggregation concentration (cac) was dependent on the DS of cholesterol moiety. Mitoxantrone (MTO), as a model anticancer drug, was loaded into the CHSP nanoparticles by dialysis method. MTO-loaded CHSP self-aggregated nanoparticles were almost spherical in shape and their size increased from 153.1 to 174.2 nm with the MTO-loading capacity increasing from 4.35% to 14.29%. The encapsulation efficiency (EE) of the process and loading capacity (LC) of the nanoparticles increased with increasing cholesterol DS. XRD powder patterns showed that crystal peaks of MTO disappeared when MTO was entrapped into CHSP nanoparticles. The release behavior of MTO from CHSP self-aggregated nanoparticles was studied in vitro. The results showed that the release behavior of MTO from CHSP nanoparticles exhibited a sustained release, and MTO release rate decreased with increasing the pH value of media.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Pullulan; cholesterol succinate; cholesterol-modified pullulan; drug delivery; mitoxantrone; self-aggregated nanoparticle

Document Type: Research Article

Publication date: June 1, 2010

More about this publication?
  • Current Nanoscience publishes authoritative reviews and original research reports, written by experts in the field on all the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano- structures, synthesis, properties, assembly and devices. Applications of nanoscience in biotechnology, medicine, pharmaceuticals, physics, material science and electronics are also covered. The journal is essential to all involved in nanoscience and its applied areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more